Table 3: Comparison among SPRINT, ACCORD, and INVEST.                

Column 1

SPRINT

ACCORD

INVEST

Cardiovascular and mortality benefits

Significant

Non-significant

Most beneficial in group 1

Participants

Non-diabetic

Diabetic

Coronary artery disease

Sample size

9361

4733

8354

Mean cohort age

67.9

62

70.7

Study objective

Intensive anti hypertension therapy

Intensive anti hypertension therapy

Efficacy of relaxed initiation therapy SBP

Baseline BP

139.7/78.1

139.2/76.0

165.4/90.2